Inc. reported its fourth-quarter 2024 earnings, showcasing an adjusted earnings per share (EPS) of $0.92, slightly surpassing the forecast of $0.90. Despite this beat, the company's stock saw a ...
AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
Tesla appears overvalued again and recommend trimming TSLA due to overly optimistic projections around future products. Click ...
Apple shares rose Friday morning after the company reported better-than-expected earnings and said customers are increasingly upgrading their iPhones to take advantage of AI features. Monitor these ...
Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...
PulteGroup (NYSE:PHM – Get Free Report) announced that its board has initiated a stock buyback program on Thursday, January 30th, RTT News reports. The company plans to repurchase $1.50 billion in ...